Systolic blood pressure and subjective well-being in patients with coronary artery disease

Clin Cardiol. 2009 Nov;32(11):627-32. doi: 10.1002/clc.20501.

Abstract

Background: Limited information exists regarding the association between subjective well-being (SWB) and systolic blood pressure (SBP) among hypertensive patients with coronary artery disease (CAD).

Hypothesis: We tested the hypothesis that there is an association between SBP and SWB.

Methods: We studied 22,576 hypertensive CAD patients > or = 50 years old in the INternational VErapamil SR-Trandolapril Study (INVEST), a randomized, blinded-endpoint trial of antihypertensive therapy in stable CAD patients. At each study visit, patients rated their SWB in the previous 4 weeks as "excellent," "good," "fair," or "poor" prior to SBP recordings. The outcome measure was SWB of "fair" or "poor." A longitudinal analysis using generalized estimating equations was performed to assess the association between SBP and odds of reporting fair/poor SWB, controlling for baseline SWB of fair/poor and angina reported during the study.

Results: Patients with higher SBP had higher odds of reporting fair/poor SWB. Specifically, compared with patients with SBP of < or = 120, patients with SBP 140-150 > 150 - < or = 160 and > 160 had about 90% and 2.5 times greater odds of feeling fair/poor, respectively (adjusted odds ratio [OR]: 1.5990, 95% confidence interval [CI]: 1.81-2.00 and adjusted OR: 2.53, 95% CI: 2.41-2.66). Those who reported angina in the 4 wks prior to a protocol visit had 2.2 times greater odds of reporting fair/poor SWB (adjusted OR: 2.2, 95% CI: 2.13-2.27). Female gender, black race, history of smoking, diabetes, myocardial infarction, stroke, and cancer also increased the odds of reporting fair/poor SWB.

Conclusions: Among hypertensive CAD patients, higher on-treatment SBP is associated with greater odds of fair/poor SWB during follow-up.

Trial registration: ClinicalTrials.gov NCT00133692.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antihypertensive Agents / therapeutic use*
  • Atenolol / therapeutic use
  • Blood Pressure / drug effects*
  • Coronary Artery Disease / complications*
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / psychology
  • Drug Therapy, Combination
  • Female
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Hypertension / psychology
  • Indoles / therapeutic use
  • Male
  • Mental Health*
  • Middle Aged
  • Odds Ratio
  • Quality of Life*
  • Risk Assessment
  • Risk Factors
  • Surveys and Questionnaires
  • Systole
  • Time Factors
  • Treatment Outcome
  • Verapamil / therapeutic use

Substances

  • Antihypertensive Agents
  • Indoles
  • trandolapril
  • Atenolol
  • Verapamil

Associated data

  • ClinicalTrials.gov/NCT00133692